Logo image of ZAL.DE

ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

FRA:ZAL - DE000ZAL1111 - Common Stock

24.75 EUR
+0.31 (+1.27%)
Last: 9/5/2025, 11:57:44 AM
Fundamental Rating

6

Overall ZAL gets a fundamental rating of 6 out of 10. We evaluated ZAL against 51 industry peers in the Specialty Retail industry. ZAL scores excellent on profitability, but there are some minor concerns on its financial health. ZAL is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes ZAL very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ZAL was profitable.
In the past year ZAL had a positive cash flow from operations.
ZAL had positive earnings in each of the past 5 years.
In the past 5 years ZAL always reported a positive cash flow from operatings.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of ZAL (3.33%) is better than 72.55% of its industry peers.
Looking at the Return On Equity, with a value of 9.70%, ZAL is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
ZAL's Return On Invested Capital of 6.07% is fine compared to the rest of the industry. ZAL outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ZAL is significantly below the industry average of 8.49%.
The 3 year average ROIC (3.34%) for ZAL is below the current ROIC(6.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.33%
ROE 9.7%
ROIC 6.07%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 2.47%, ZAL is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
ZAL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 3.68%, ZAL is in line with its industry, outperforming 58.82% of the companies in the same industry.
In the last couple of years the Operating Margin of ZAL has grown nicely.
ZAL's Gross Margin of 40.66% is in line compared to the rest of the industry. ZAL outperforms 56.86% of its industry peers.
ZAL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) 2.47%
GM 40.66%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZAL is destroying value.
ZAL has less shares outstanding than it did 1 year ago.
ZAL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ZAL has an improved debt to assets ratio.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.90 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ZAL (2.90) is better than 78.43% of its industry peers.
The Debt to FCF ratio of ZAL is 7.83, which is on the high side as it means it would take ZAL, 7.83 years of fcf income to pay off all of its debts.
ZAL has a Debt to FCF ratio of 7.83. This is comparable to the rest of the industry: ZAL outperforms 49.02% of its industry peers.
ZAL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ZAL (0.40) is better than 60.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 7.83
Altman-Z 2.9
ROIC/WACC0.98
WACC6.22%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

ZAL has a Current Ratio of 1.38. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
ZAL has a better Current ratio (1.38) than 62.75% of its industry peers.
A Quick Ratio of 0.98 indicates that ZAL may have some problems paying its short term obligations.
ZAL has a better Quick ratio (0.98) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.98
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.27% over the past year.
ZAL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.33% yearly.
The Revenue has been growing slightly by 7.12% in the past year.
ZAL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.28% yearly.
EPS 1Y (TTM)76.27%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%0%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.26%

3.2 Future

ZAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.15% yearly.
The Revenue is expected to grow by 10.15% on average over the next years. This is quite good.
EPS Next Y31.4%
EPS Next 2Y26.24%
EPS Next 3Y24.32%
EPS Next 5Y26.15%
Revenue Next Year13.22%
Revenue Next 2Y12.2%
Revenue Next 3Y10.1%
Revenue Next 5Y10.15%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.80, ZAL is valued on the expensive side.
Based on the Price/Earnings ratio, ZAL is valued a bit cheaper than 64.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. ZAL is around the same levels.
A Price/Forward Earnings ratio of 16.01 indicates a correct valuation of ZAL.
62.75% of the companies in the same industry are more expensive than ZAL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.63. ZAL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.8
Fwd PE 16.01
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZAL is valued a bit cheaper than 68.63% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZAL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.4
EV/EBITDA 6.54
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ZAL may justify a higher PE ratio.
ZAL's earnings are expected to grow with 24.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)1.02
EPS Next 2Y26.24%
EPS Next 3Y24.32%

0

5. Dividend

5.1 Amount

No dividends for ZAL!.
Industry RankSector Rank
Dividend Yield N/A

ZALANDO SE

FRA:ZAL (9/5/2025, 11:57:44 AM)

24.75

+0.31 (+1.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06
Inst Owners62.55%
Inst Owner ChangeN/A
Ins Owners10.07%
Ins Owner ChangeN/A
Market Cap6.54B
Analysts78.18
Price Target37.6 (51.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)444.88%
Min EPS beat(2)-2.31%
Max EPS beat(2)892.08%
EPS beat(4)3
Avg EPS beat(4)227.19%
Min EPS beat(4)-2.31%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)70.96%
EPS beat(12)6
Avg EPS beat(12)0.99%
EPS beat(16)7
Avg EPS beat(16)-20.02%
Revenue beat(2)1
Avg Revenue beat(2)0.58%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)1.19%
Revenue beat(4)2
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)1.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)-3.88%
PT rev (3m)-5.08%
EPS NQ rev (1m)-8.11%
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.01%
EPS NY rev (3m)6.01%
Revenue NQ rev (1m)16.04%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.22%
Revenue NY rev (3m)6.08%
Valuation
Industry RankSector Rank
PE 23.8
Fwd PE 16.01
P/S 0.6
P/FCF 30.4
P/OCF 15.75
P/B 2.34
P/tB 2.77
EV/EBITDA 6.54
EPS(TTM)1.04
EY4.2%
EPS(NY)1.55
Fwd EY6.25%
FCF(TTM)0.81
FCFY3.29%
OCF(TTM)1.57
OCFY6.35%
SpS41.42
BVpS10.57
TBVpS8.94
PEG (NY)0.76
PEG (5Y)1.02
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 9.7%
ROCE 9.91%
ROIC 6.07%
ROICexc 17.63%
ROICexgc 25.4%
OM 3.68%
PM (TTM) 2.47%
GM 40.66%
FCFM 1.97%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ROICexc(3y)9.52%
ROICexc(5y)14.27%
ROICexgc(3y)13.4%
ROICexgc(5y)19.23%
ROCE(3y)5.45%
ROCE(5y)7.5%
ROICexcg growth 3Y8.96%
ROICexcg growth 5Y22.36%
ROICexc growth 3Y2.72%
ROICexc growth 5Y17.49%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 7.83
Debt/EBITDA 1.48
Cap/Depr 55.44%
Cap/Sales 1.83%
Interest Coverage 250
Cash Conversion 54.37%
Profit Quality 79.43%
Current Ratio 1.38
Quick Ratio 0.98
Altman-Z 2.9
F-Score7
WACC6.22%
ROIC/WACC0.98
Cap/Depr(3y)86.74%
Cap/Depr(5y)104.05%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.86%
Profit Quality(3y)549.88%
Profit Quality(5y)378.62%
High Growth Momentum
Growth
EPS 1Y (TTM)76.27%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%0%
EPS Next Y31.4%
EPS Next 2Y26.24%
EPS Next 3Y24.32%
EPS Next 5Y26.15%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.26%
Revenue Next Year13.22%
Revenue Next 2Y12.2%
Revenue Next 3Y10.1%
Revenue Next 5Y10.15%
EBIT growth 1Y40.95%
EBIT growth 3Y-1.58%
EBIT growth 5Y18.79%
EBIT Next Year114.38%
EBIT Next 3Y39.75%
EBIT Next 5Y36.98%
FCF growth 1Y-69.35%
FCF growth 3Y16.44%
FCF growth 5Y84.9%
OCF growth 1Y-58.04%
OCF growth 3Y2.01%
OCF growth 5Y14.86%